Implantable Sleep Aide Neurostimulation Device
Total Trials
9
As Lead Sponsor
7
As Collaborator
2
Total Enrollment
702
NCT02312479
Safety and Performance Study of the Nyxoah SAT System for Treating OSA
Phase: N/A
Role: Lead Sponsor
Start: Dec 31, 2014
Completion: Apr 30, 2016
NCT03048604
BiLAteral Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnoea (BLAST OSA)
Start: Mar 30, 2017
Completion: Sep 10, 2018
NCT03763682
BilatEral Hypoglossal Nerve StimulaTion for TreatmEnt of ObstRuctive SLEEP Apnoea With and Without Complete Concentric Collapse
Start: Jan 10, 2019
Completion: Jun 18, 2024
NCT04031040
A Post-market Clinical Follow up of the Genio™ System for the Treatment of Obstructive Sleep Apnea in Adults
Start: Sep 1, 2019
Completion: Oct 30, 2025
NCT03868618
Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM)
Start: Oct 14, 2020
Completion: Feb 29, 2028
Role: Collaborator
NCT05592002
Safety and Effectiveness of the Genio® bilAteral Stimulation for Treatment of Complete Concentric CollapsE and OSA.
Start: Dec 28, 2022
Completion: Sep 30, 2028
NCT05939141
An Extension Study to Assess the Long-term Safety of the Genio® System
Start: Nov 30, 2025
Completion: Jul 17, 2029
Loading map...